<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526275</url>
  </required_header>
  <id_info>
    <org_study_id>CI-B002</org_study_id>
    <nct_id>NCT04526275</nct_id>
  </id_info>
  <brief_title>Development of Validated Bruise Scale in HNV</brief_title>
  <official_title>Development of a Bruise Scale in Healthy Normal Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cearna, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cearna, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects will have a mechanically induced bruise photographed over a period of 11 days to&#xD;
      record the healing process. Assessors will rate the bruises to develop a bruising scale.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational study. Healthy normal volunteers will come into the clinic and have a bruise&#xD;
      induced. The bruised area will be photographed each day through Day 11. Images will be&#xD;
      provided to the Validator Team to rate on a 0-5 scale of severity.&#xD;
&#xD;
      The actual numbers of volunteers will be adjusted to ensure there are at least 15 images for&#xD;
      each Grade.&#xD;
&#xD;
      The clinical site will be provided photography equipment, and study staff will be trained on&#xD;
      photography technique to standardize the image quality and resolution across the study.&#xD;
&#xD;
      The Validator Team will review the images and categorize them in to Grades 0-5.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 25, 2020</start_date>
  <completion_date type="Anticipated">April 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bruise Healing over time</measure>
    <time_frame>11 days</time_frame>
    <description>Record bruise images over 11 days</description>
  </primary_outcome>
  <enrollment type="Actual">27</enrollment>
  <condition>Bruise, Contusion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy Normal Volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fitzpatrick skin type 1-3&#xD;
&#xD;
          -  BMI 25 kg/m2&#xD;
&#xD;
          -  Self described bruisers&#xD;
&#xD;
          -  Intact skin in the target area, free of markings, blemishes and hair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of recreational drugs, steroids, pain medications, other homeopathic remedies,&#xD;
             anticoagulant therapies, antiplatelet therapy&#xD;
&#xD;
          -  Known history of dermal sensitivity, serious illness, hematological abnormality,&#xD;
             impaired wound healing&#xD;
&#xD;
          -  Inability to forego application of topical products in the target area&#xD;
&#xD;
          -  Hair removal by laser, wax or chemicals within one week prior to Day 1&#xD;
&#xD;
          -  Avoid tanning beds&#xD;
&#xD;
          -  Active wound or infection in the target area&#xD;
&#xD;
          -  History of keloids or hypertrophic scarring&#xD;
&#xD;
          -  History of collagen or vascular disease&#xD;
&#xD;
          -  History of organ transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Artemis Clinical Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ecchymosis</mesh_term>
    <mesh_term>Contusions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Aggregate data will be shared and published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

